Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
Savara launches an Early Access Program for molgramostim inhalation solution, aimed at patients with Autoimmune Pulmonary Alveolar Proteinosis. This initiative provides critical access to treatment for a rare disease affecting lung function.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.